BayGam (immune globulin) should not be given to persons with isolated immunoglobulin A (IgA)
deficiency. Such persons have the potential for developing antibodies to IgA
and could have anaphylactic reactions to subsequent administration of blood
products that contain IgA.9 BayGam (immune globulin) should not be administered to
patients who have severe thrombocytopenia or any coagulation disorder that would
contraindicate intramuscular injections.
REFERENCE
9. Fudenberg HH: Sensitization to immunoglobulins and hazards
of gamma globulin therapy. In: Merler E (ed.): Immunoglobulins: biologic aspects
and clinical uses. Washington DC, Nat Acad Sci, 1970, pp 211-20.
Last reviewed on RxList: 11/13/2008
This monograph has been modified to include the generic and brand name in many instances.